March 28, 2025--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird") today confirmed ... to understand the safety of our lentiviral vector technologies and drive the field of gene ...

Inc. ("bluebird") today confirmed it has received an unsolicited non-binding written proposal (the "Ayrmid Proposal") from Ayrmid Ltd ("Ayrmid") to acquire bluebird for an upfront cash payment of ...

Despite groundbreaking gene therapies, bluebird bio faces ... renting out its vector platform and manufacturing expertise to other companies. BLUE has been championing gene therapy for decades ...

The mathematician Tai-Danae Bradley is using category theory to try to understand both human and AI-generated language.

Choose from Blue Bird Illustration stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection ...

MeiraGTx's innovative gene therapies for ocular diseases & more are backed by strong clinical data and funding. Click here to find out why MGTX stock is a Buy.

Choose from Sun Bird Vector stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...

Historically, the lake was used to cleanse the bones of the dead before their spirits returned to the ancestral homeland.

Sporting clays makes it terrific practice for field shooting, even if the targets sometimes fly in ways that no real bird ever could ... A400 was unmistakable on the course due to its bright blue ...

In a report released today, Eric Stine from Craig-Hallum maintained a Buy rating on Blue Bird (BLBD – Research Report). The company’s shares ...